Back to search

France· FR:65501436

VIRAMUNE 50 mg/5 ml, suspension buvable

A medicinal product containing névirapine hémihydratée, registered in France by BOEHRINGER INGELHEIM INTERNATIONAL.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVIRAMUNE 50 mg/5 ml, suspension buvab…ATC—REGISTER NO.FR:65501436PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
NÉVIRAPINE HÉMIHYDRATÉE
Manufacturer
BOEHRINGER INGELHEIM INTERNATIONAL
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400935210241
    1 flacon(s) polyéthylène haute densité (PEHD) de 240 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Névirapine hémihydratée in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All névirapine hémihydratée products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Nevirapin Viatris
  • Belgium · Nevirapine Viatris
  • Germany · Nevirapin Abdi, Nevirapin Aurobindo
  • Denmark · Nevirapine Medical Valley, Nevirapine Viatris
  • Spain · Nevirapina Aurovitas, Nevirapina Kern Pharma
  • Finland · Nevirapine Viatris
  • United Kingdom (Northern Ireland) · Nevirapine Accord, Nevirapine Accord Healthcare
  • Greece · Nevirapine Vocate
  • Iceland · Viramune
  • Italy · Nevirapina Aurobindo, Nevirapina Mylan
  • Liechtenstein · Viramune
  • Luxembourg · Nevirapine Viatris
  • Netherlands · Nevirapine Accord, Nevirapine Amarox
  • Norway · Viramune
  • Portugal · Nevirapina Accord, Nevirapina Aurovitas
  • Romania · Nevirapina Accord, Nevirapină Accord
  • Sweden · Nevirapine Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/dad636c3-da6b-4663-b299-879eae2df7f9
GET /v1/drugs/dad636c3-da6b-4663-b299-879eae2df7f9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65501436",
  "date_amm": "1999-06-18",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/97/055",
  "substance": "NÉVIRAPINE HÉMIHYDRATÉE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "suspension buvable",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about névirapine hémihydratée.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.